HALO - Halozyme Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

HALO is currently covered by 9 analysts with an average price target of $51.25. This is a potential upside of $10.52 (25.83%) from yesterday's end of day stock price of $40.73.

Halozyme Therapeutics's activity chart (see below) currently has 117 price targets and 103 ratings on display. The stock rating distribution of HALO is 94.44% BUY and 5.56% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.55% with an average time for these price targets to be met of 194 days.

Highest price target for HALO is $72, Lowest price target is $40, average price target is $51.25.

Most recent stock forecast was given by JASON BUTLER from JMP on 21-Feb-2024. First documented stock forecast 11-Jun-2014.

Currently out of the existing stock ratings of HALO, 34 are a BUY (94.44%), 2 are a HOLD (5.56%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

72

$31.27 (76.77%)

72

1 months 7 days ago

5/10 (50%)

$33.64 (87.70%)

244

Buy

50

$9.27 (22.76%)

48

1 months 7 days ago

0/8 (0%)

$11.64 (30.34%)

Buy

50

$9.27 (22.76%)

50

2 months 9 days ago

0/3 (0%)

$15.85 (46.41%)

Buy

48

$7.27 (17.85%)

52

2 months 10 days ago

0/4 (0%)

$13.07 (37.42%)

Hold

40

$-0.73 (-1.79%)

45

2 months 10 days ago

5/6 (83.33%)

$5.07 (14.51%)

243

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HALO (Halozyme Therapeutics) average time for price targets to be met?

On average it took 194 days on average for the stock forecasts to be realized with a an average price target met ratio 58.55

Which analyst has the current highest performing score on HALO (Halozyme Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on HALO

Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?

Jason Butler with highest potential upside - $31.27

Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?

Eun Yang with lowest potential downside - -$27.73

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?